Rosemont acquires Lucis Pharma to boost portfolio
Company will gain access to a considerable pipeline of liquid products covering various disease areas
Read More
Tag: lucis
- KCL researchers identify key features of autoimmune diseases present in the gut
- Vicore and Endeavor’s therapies show promise in treating IPF
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
